Autolomous is an biotechnology company engaged in manufacturing pragmatic digital solutions for cell and gene therapy.
Autolomous has raised $4.4M in total funding. The most recent round was Convertible Note. The last funding was announced in March 2025.
Autolomous's investors include Innovate UK, BioTools Innovator.
Autolomous is headquartered in London, United Kingdom.
Autolomous is an biotechnology company engaged in manufacturing pragmatic digital solutions for cell and gene therapy.
Autolomous is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Autolomous — Funding & Investors." VCBacked, March 1, 2025, https://www.vcbacked.co/company/autolomous. Accessed August 14, 2026.
VCBacked. (2025). Autolomous — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/autolomous
{{cite web |title=Autolomous — Funding & Investors |url=https://www.vcbacked.co/company/autolomous |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated